Pharmaceutical Description
Value proposition
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Find out more at https://www.novartis.com
See our community guidelines: https://go.novartis.social/3Nboxki
Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy
Novartis
Novartis
https://www.novartis.com/
Entity interactions BETA
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | 24ORE Business School Professional Training and Coaching | Other 3 Mar 2024 | | |
 | AbCellera biotech, deeptech, Biotechnology Research | Not capitalistic Partnership Event 7 Jan 2023 | | |
 | ABLE - Association of Biotechnology Led Enterprises deeptech, Biotechnology Research | Other 31 Jan 2023 | | |
 | AceUp HRtech, civictech, edtech, Professional Training and Coaching | Other 7 May 2023 | | |
 | Acteurs de La French Care healthtech, Hospitals and Health Care | Other 7 Dec 2023 | | |
 | Act Venture Capital Venture Capital and Private Equity Principals | Other 24 Apr 2024 | | |
 | Adaptive Climbing Group entertainment, Spectator Sports | Other 4 Oct 2023 | | |
 | Advanced Accelerator Applications biotech, deeptech, Pharmaceutical Manufacturing | Other 25 Dec 2022 | | |
 | aescuvest Venture Capital and Private Equity Principals | Other 31 Oct 2022 | | |
 | AfricInvest Group Financial Services | Other 16 Nov 2023 | | |
Radars
Last news Show all articles
Loading...